ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–14. doi: 10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Song B, Ding C, Chen W, et al. Incidence and mortality of cervical cancer in China, 2013. Chin J Cancer Res. 2017;29(6):471–476. doi: 10.21147/j.issn.1000-9604.2017.06.01
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi: 10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Simms KT, Steinberg J, Caruana M, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 2019;20:394–407. doi: 10.1016/S1470-2045(18)30836-2.
   PubMed Web of Science ®Google Scholar
• Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136(4):586–591. doi: 10.1016/j.cell.2009.02.005
   PubMed Web of Science ®Google Scholar
• Li P, Zhang Q, Tang H. Retracted: INPP1 up-regulation by miR-27a contributes to the growth, migration and invasion of human cervical cancer. J Cell Mol Med. 2019;23(11):7709–7716. doi: 10.1111/jcmm.14644
   PubMed Web of Science ®Google Scholar
• Wu H, Liu C, Yang Q, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy. 2019;16(4):1–15. doi: 10.1080/15548627.2019.1635380
   PubMed Web of Science ®Google Scholar
• Borkowska EM, Konecki T, Pietrusinski M, et al. MicroRNAs which can prognosticate aggressiveness of bladder cancer. Cancers (Basel). 2019;11(10):11. doi: 10.3390/cancers11101551
   Web of Science ®Google Scholar
• Lin X, Wang S, Sun M, et al. miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization. J Hematol Oncol. 2019;12:20. doi: 10.1186/s13045-019-0708-7.
   PubMed Web of Science ®Google Scholar
• Gao X, Lu M, Xu W, et al. miR-195 inhibits esophageal cancer cell proliferation and promotes apoptosis by downregulating YAP1. Int J Clin Exp Pathol. 2019;12:275–281.
   PubMed Web of Science ®Google Scholar
• Niu J, Wang Y, Hu Y, et al. Mechanisms of miR-195-5p and FOXK1 in rat xenograft models of non-small cell lung cancer. Am J Transl Res. 2021;13:2528–2536.
   PubMed Web of Science ®Google Scholar
• Yang R, Xing L, Zheng X, et al. RETRACTED ARTICLE: the circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019;18(1):4. doi: 10.1186/s12943-018-0933-7
   PubMed Web of Science ®Google Scholar
• Liu X, Zhou Y, Ning YE, et al. MiR-195-5p inhibits malignant progression of cervical cancer by targeting YAP1. Onco Targets Ther. 2020;13:931–944. doi: 10.2147/OTT.S227826.
   PubMed Web of Science ®Google Scholar
• Wang N, Wei H, Yin D, et al. MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. Tumour Biol. 2016;37:4711–4720. doi: 10.1007/s13277-015-4292-3.
   PubMedGoogle Scholar
• Zhou Q, Han LR, Zhou YX, et al. MiR-195 suppresses cervical cancer migration and invasion through targeting Smad3. Int J Gynecol Cancer. 2016;26(5):817–824. doi: 10.1097/IGC.0000000000000686
   PubMed Web of Science ®Google Scholar
• Imai K, Hao F, Fujita N, et al. Atg9A trafficking through the recycling endosomes is required for autophagosome formation. J Cell Sci. 2016;129:3781–3791. doi: 10.1242/jcs.196196.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Nuhlen S, Judith D, et al. TBC1D14 regulates autophagy via the TRAPP complex and ATG9 traffic. EMBO J. 2016;35:281–301. doi: 10.15252/embj.201592695.
   PubMed Web of Science ®Google Scholar
• Bhat P, Kriel J, Shubha Priya B, et al. Loos, modulating autophagy in cancer therapy: advancements and challenges for cancer cell death sensitization. Biochem Pharmacol. 2018;147:170–182. doi: 10.1016/j.bcp.2017.11.021.
   PubMed Web of Science ®Google Scholar
• Tang JY, Hsi E, Huang YC, et al. ATG9A overexpression is associated with disease recurrence and poor survival in patients with oral squamous cell carcinoma. Virchows Arch. 2013;463:737–742. doi: 10.1007/s00428-013-1482-5.
   PubMed Web of Science ®Google Scholar
• Dai F, Zhang Y, Chen Y. Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma. Hum Pathol. 2014;45:1285–1293. doi: 10.1016/j.humpath.2014.02.008.
   PubMed Web of Science ®Google Scholar
• Claude-Taupin A, Fonderflick L, Gauthier T, et al. ATG9A is overexpressed in triple negative breast cancer and its in vitro extinction leads to the inhibition of pro-cancer phenotypes. Cells. 2018;7(12):248. doi: 10.3390/cells7120248
   PubMed Web of Science ®Google Scholar
• Pang J, Xiong H, Lin P, et al. Activation of miR-34a impairs autophagic flux and promotes cochlear cell death via repressing ATG9A: implications for age-related hearing loss. Cell Death Dis. 2017;8:e3079. doi: 10.1038/cddis.2017.462.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yang J, Li F, et al. MiR-29a inhibited intestinal epithelial cells autophagy partly by decreasing ATG9A in ulcerative colitis. Anticancer Drugs. 2018;29(7):652–659. doi: 10.1097/CAD.0000000000000636
   PubMed Web of Science ®Google Scholar
• Wen Y, Gong X, Dong Y, et al. Long non coding RNA SNHG16 facilitates proliferation, migration, invasion and autophagy of neuroblastoma cells via sponging miR-542-3p and upregulating ATG5 expression. Onco Targets Ther. 2020;13:263–275. doi: 10.2147/OTT.S226915.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, San Juan BP, Lim E, et al. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35(4):645–654. doi: 10.1007/s10555-016-9648-7
   PubMed Web of Science ®Google Scholar
• Delcour C, Amazit L, Patino LC, et al. ATG7 and ATG9A loss-of-function variants trigger autophagy impairment and ovarian failure. Genet Med. 2019;21(4):930–938. doi: 10.1038/s41436-018-0287-y
   PubMed Web of Science ®Google Scholar
• Bai J, Xu J, Zhao J, et al. lncRNA SNHG1 cooperated with miR-497/miR-195-5p to modify epithelial–mesenchymal transition underlying colorectal cancer exacerbation. J Cell Physiol. 2019;235(2):1453–1468. doi: 10.1002/jcp.29065
   PubMed Web of Science ®Google Scholar
• Liang M, Huang G, Liu Z, et al. Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR-195/GPRC5A signalling. Cell Prolif. 2019;52(5):e12661. doi: 10.1111/cpr.12661
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhao M, Du Y, et al. MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin. Thorac Cancer. 2019;10:1419–1430. doi: 10.1111/1759-7714.13087.
   PubMed Web of Science ®Google Scholar
• Chen LP, Zhang NN, Ren XQ, et al. miR-103/miR-195/miR-15b regulate SALL4 and inhibit proliferation and migration in glioma. Molecules. 2018;23(11):2938. doi: 10.3390/molecules23112938
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–463. doi: 10.1038/nature02625.
   PubMed Web of Science ®Google Scholar
• Miao CG, Yang YY, He X, et al. New advances of microRnas in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. Cell Signal. 2013;25:1118–1125. doi: 10.1016/j.cellsig.2013.01.024.
   PubMed Web of Science ®Google Scholar
• Botezatu A, Goia-Rusanu CD, Iancu IV, et al. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis. Mol Med Rep. 2011;4:121–128. doi: 10.3892/mmr.2010.394.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang HK, McCoy JP, et al. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA. 2009;15:637–647. doi: 10.1261/rna.1442309.
   PubMed Web of Science ®Google Scholar
• Wilting SM, Snijders PJ, Verlaat W, et al. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene. 2013;32(1):106–116. doi: 10.1038/onc.2012.20
   PubMed Web of Science ®Google Scholar
• Nicoloso MS, Sun H, Spizzo R, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010;70(7):2789–2798. doi: 10.1158/0008-5472.CAN-09-3541
   PubMed Web of Science ®Google Scholar
• Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12. doi: 10.1186/s12943-020-1138-4
   PubMed Web of Science ®Google Scholar
• Kwon JJ, Willy JA, Quirin KA, et al. Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential. Oncotarget. 2016;7(44):71635–71650. doi: 10.18632/oncotarget.11928
   PubMedGoogle Scholar
• Zhu S, Tang X, Gao X, et al. hsa_circ_0013401 accelerates the growth and metastasis and prevents apoptosis and autophagy of neuroblastoma cells by sponging miR-195 to release PAK2. Oxid Med Cell Longev. 2021;2021:9936154. doi: 10.1155/2021/9936154.
   PubMedGoogle Scholar
• Jolly MK, Celia-Terrassa T. Dynamics of phenotypic heterogeneity during EMT and stemness in cancer progression. J Clin Med. 2019;8:1542. doi: 10.3390/jcm8101542.
   PubMed Web of Science ®Google Scholar
• Loh CY, Chai JY, Tang TF, et al. The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling. Cells. 2019;8(10):1118. doi: 10.3390/cells8101118
   PubMed Web of Science ®Google Scholar
• Orsi A, Razi M, Dooley HC, et al. Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol Biol Cell. 2012;23(10):1860–1873. doi: 10.1091/mbc.e11-09-0746
   PubMed Web of Science ®Google Scholar